NGL Fine Chem Share Price | NGL Fine Chem Stock Screener
NGLFINE
Pharmaceuticals
Share Price NSE
₹2697.60
▼
-122.20 (-4.33%)
Share Price BSE
₹2700.65
▼
-126.50 (-4.47%)
As of May 27, 2026, the NGL Fine Chem share price (NSE: NGLFINE) is ₹2,697.60 on NSE and ₹2,700.65 on BSE, down 4.33% from the previous close, with shares trading between ₹2,636.00 and ₹2,878.40, and a 52-week range of ₹995.00–₹2,858.90.
Check NGL Fine Chem yearly highs lows for the annual price range and momentum.
Use the NGL Fine Chem stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
NGL Fine Chem Market Cap
₹1,690.20 Cr.
NGLFINE P/E Ratio (TTM)
35.57
NGL Fine Chem P/B Ratio
5.20
EPS (TTM)
₹77.90
Dividend Yield
-
Debt to Equity
0.20
NGLFINE 52 Week High
₹2858.90
NGL Fine Chem 52 Week Low
₹995.00
Operating Margin
14.00%
Profit Margin
9.21%
NGLFINE Revenue (TTM)
₹152.00
EBITDA
₹24.00
Net Income
₹14.00
Total Assets
₹546.00
Total Equity
₹329.00
NGL Fine Chem Share Price Chart
Screen NGL Fine Chem share price with an interactive chart. Analyse NGLFINE price trends and volatility across different timeframes.
NGL Fine Chem Company Profile - Fundamental Screener
Screen NGL Fine Chem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for NGLFINE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE887E01022
NGL Fine Chem Balance Sheet Screener
Screen NGLFINE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 546 | 433 | 356 | 287 | 277 | 207 | 154 | 142 |
| Current Assets | 276 | 235 | 213 | 163 | 174 | 125 | 81 | 79 |
| Fixed Assets | 259 | 143 | 86 | 88 | 89 | 64 | 68 | 61 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 66 | 32 | 6 | 6 | 8 | 11 | 12 | 12 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 329 | 282 | 263 | 223 | 203 | 155 | 99 | 92 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 326 | 279 | 260 | 220 | 200 | 151 | 96 | 89 |
NGL Fine Chem Income Statement Screener - Profit & Revenue Analysis
Screen NGL Fine Chem income statement and profit fundamentals.
Analyze NGLFINE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for NGL Fine Chem share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 152 | 132 | 122 | 111 | 94 | 89 | 99 | 97 | 103 | 92 | 83 | 74 | 76 | 73 | 68 |
| Expenses | 128 | 105 | 103 | 93 | 89 | 84 | 82 | 81 | 84 | 74 | 66 | 61 | 61 | 62 | 59 |
| EBITDA | 24 | 27 | 19 | 17 | 5 | 5 | 17 | 15 | 20 | 18 | 17 | 13 | 15 | 11 | 10 |
| Operating Profit % | 14.00% | 18.00% | 14.00% | 11.00% | 7.00% | 6.00% | 12.00% | 10.00% | 16.00% | 16.00% | 17.00% | 14.00% | 19.00% | 14.00% | 14.00% |
| Depreciation | 5 | 5 | 5 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 18 | 21 | 13 | 12 | 1 | 1 | 13 | 12 | 16 | 14 | 14 | 10 | 12 | 9 | 6 |
| Tax | 4 | 5 | 3 | 3 | 1 | 0 | 4 | 3 | 4 | 4 | 4 | 2 | 3 | 3 | 2 |
| Net Profit | 14 | 16 | 10 | 9 | 1 | 1 | 10 | 9 | 12 | 10 | 11 | 9 | 9 | 7 | 5 |
| EPS | 21.83 | 25.40 | 15.58 | 14.96 | 0.88 | 2.07 | 15.88 | 14.92 | 19.95 | 16.24 | 16.96 | 13.77 | 15.09 | 10.50 | 7.56 |
NGL Fine Chem Cash Flow Screener - Liquidity Fundamentals
Screen NGLFINE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 36 | 21 | 35 | 14 | 27 | 21 | 9 |
| Investing Activities | -35 | -27 | -27 | -14 | -25 | -20 | -10 |
| Financing Activities | -1 | -1 | -1 | -1 | -1 | -1 | 0 |
| Net Cash Flow | 0 | -7 | 7 | -2 | 2 | 0 | -1 |
NGL Fine Chem Shareholding Pattern Screener
See NGL Fine Chem shareholding pattern with promoter, FII, and DII holdings.
Check NGL Fine Chem promoter holding and ownership changes for NGLFINE on TickJournal.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% |
| FII Holding | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.02% | 0.03% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 22.66% | 22.92% | 23.01% | 23.00% | 22.75% | 21.70% | 21.69% | 21.81% |
| Other Holding | 4.57% | 4.34% | 4.25% | 4.27% | 4.51% | 5.56% | 5.56% | 5.42% |
| Shareholder Count | 12,516 | 12,834 | 13,387 | 14,010 | 14,386 | 14,110 | 14,575 | 14,608 |
NGL Fine Chem Share Dividend Screener - Share Yield Analysis
Check NGL Fine Chem dividend history with payout and yield data.
View NGL Fine Chem dividend details including ex-dates and amounts for NGLFINE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.75 | 0.09% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹1.75 | 0.08% |
| 2022-March | ₹1.75 | 0.14% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
NGL Fine Chem Stock Index Membership
See which indices include NGL Fine Chem stock.
Check NGLFINE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP
NGL Fine Chem Market Events Screener - Corporate Actions
Get NGL Fine Chem corporate actions including splits, bonuses, and buybacks.
Check NGL Fine Chem stock events that may affect NGLFINE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-25 | 2026-08-25 | Annual General Meeting | NA | 14.70% |
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | 2.91% |
| 2026-02-03 | 2026-02-03 | Quarterly Result Announcement | NA | 22.32% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -3.76% |
| 2025-08-19 | 2025-08-19 | Annual General Meeting | NA | 6.27% |
| 2025-08-12 | 2025-08-12 | Dividend | ₹ 1.75 /share | -5.32% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | -0.55% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 15.10% |
| 2025-02-07 | 2025-02-07 | Quarterly Result Announcement | NA | 16.09% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | 9.98% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | -1.27% |
| 2024-08-16 | 2024-08-16 | Dividend | ₹ 1.75 /share | -0.27% |
| 2023-08-18 | 2023-08-18 | Dividend | ₹ 1.75 /share | 31.25% |
| 2022-06-22 | 2022-06-23 | Dividend | ₹ 1.75 /share | -23.99% |
| 2021-08-12 | 2021-08-13 | Dividend | ₹ 1.75 /share | 79.24% |
NGL Fine Chem Competitors Screener - Peer Comparison
Screen NGLFINE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 442,581 | 40.42 | 58,220 | 6.38% | 11,565 | 54.75 |
| Divis Laboratories | 182,828 | 73.73 | 10,560 | 8.73% | 2,520 | 66.48 |
| Torrent Pharmaceuticals | 151,833 | 66.80 | 13,753 | 19.18% | 2,028 | 61.90 |
| Cipla | 113,025 | 29.26 | 27,712 | -2.46% | 3,783 | 61.92 |
| Dr Reddys Laboratories | 109,105 | 26.24 | 33,593 | -0.44% | 3,998 | 52.61 |
| Zydus Life Science | 104,543 | 20.40 | 26,720 | 13.65% | 5,242 | 69.40 |
| Lupin | 104,288 | 19.46 | 27,488 | 19.98% | 5,345 | 47.33 |
| Mankind Pharma | 102,351 | 52.84 | 14,278 | 12.03% | 1,750 | 62.34 |
| Aurobindo Pharma | 85,000 | 24.29 | 33,385 | 3.21% | 3,376 | 52.91 |
| Laurus Labs | 72,530 | 81.46 | 6,813 | 21.03% | 884 | 77.10 |
NGL Fine Chem Company Announcements - News Screener
Screen NGLFINE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-26 | Outcome Of Board Meeting | - |
| 2026-05-26 | Outcome Of Board Meeting Held On May 21 2026 | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-26 | Corporate Action-Board approves Dividend | - |
| 2026-05-26 | Audited Financial Results (Standalone& Consolidated) Along With Statutory AuditorS Report For The Quarter And Year Ended On March 31 2026 Pursuant To Regulation 33 Of SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015 | - |
| 2026-05-26 | Board Meeting Outcome for Outcome Of The Board Meeting Dated May 21 2026 | - |
| 2026-05-25 | Update on board meeting | - |
| 2026-05-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-22 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-04-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-27 | Closure of Trading Window | - |
| 2026-03-13 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-03 | Disclosure under Regulation 30A of LODR | - |
| 2026-02-03 | Outcome Of Board Meeting | - |
| 2026-02-03 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-01-12 | Board Meeting Intimation for Board Meeting Intimation | - |